These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32126871)

  • 1. Subgroup analysis based on structured mixed-effects models for longitudinal data.
    Shen J; Qu A
    J Biopharm Stat; 2020 Jul; 30(4):607-622. PubMed ID: 32126871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous growth bent-cable models for time-to-event and longitudinal data: application to AIDS studies.
    Dagne GA
    J Biopharm Stat; 2018; 28(6):1216-1230. PubMed ID: 29953318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A semiparametric Bayesian approach to the random effects model.
    Kleinman KP; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partially linear mixed-effects joint models for skewed and missing longitudinal competing risks outcomes.
    Lu T; Lu M; Wang M; Zhang J; Dong GH; Xu Y
    J Biopharm Stat; 2019; 29(6):971-989. PubMed ID: 29252088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Copula Approach to Joint Modeling of Longitudinal Measurements and Survival Times Using Monte Carlo Expectation-Maximization with Application to AIDS Studies.
    Ganjali M; Baghfalaki T
    J Biopharm Stat; 2015; 25(5):1077-99. PubMed ID: 25372017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusting for regression toward the mean when variables are normally distributed.
    Lin HM; Hughes MD
    Stat Methods Med Res; 1997 Jun; 6(2):129-46. PubMed ID: 9261912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demystifying optimal dynamic treatment regimes.
    Moodie EE; Richardson TS; Stephens DA
    Biometrics; 2007 Jun; 63(2):447-55. PubMed ID: 17688497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretable inference on the mixed effect model with the Box-Cox transformation.
    Maruo K; Yamaguchi Y; Noma H; Gosho M
    Stat Med; 2017 Jul; 36(15):2420-2434. PubMed ID: 28294388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian inference on mixed-effects location scale models with skew-t distribution and mismeasured covariates for longitudinal data.
    Lu T
    Stat Med; 2017 Jul; 36(16):2614-2629. PubMed ID: 28421622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian nonparametric mixed-effects joint model for longitudinal-competing risks data analysis in presence of multiple data features.
    Lu T
    Stat Methods Med Res; 2017 Oct; 26(5):2407-2423. PubMed ID: 26265770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous inference for semiparametric mixed-effects joint models with skew distribution and covariate measurement error for longitudinal competing risks data analysis.
    Lu T
    J Biopharm Stat; 2017; 27(6):1009-1027. PubMed ID: 28272995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMRM vs joint modeling of longitudinal responses and time to study drug discontinuation in clinical trials using a "de jure" estimand.
    García-Hernandez A; Pérez T; Pardo MDC; Rizopoulos D
    Pharm Stat; 2020 Nov; 19(6):909-927. PubMed ID: 32725810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian joint modeling of longitudinal measurements and time-to-event data using robust distributions.
    Baghfalaki T; Ganjali M; Hashemi R
    J Biopharm Stat; 2014; 24(4):834-55. PubMed ID: 24697192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic nonlinear model for censored and mismeasured covariates in longitudinal models, with application in AIDS studies.
    Zhang H; Wong H; Wu L
    Stat Med; 2018 Jan; 37(1):167-178. PubMed ID: 29034494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing efficiency from censored survival data by using random effects to model longitudinal covariates.
    Hogan JW; Laird NM
    Stat Methods Med Res; 1998 Mar; 7(1):28-48. PubMed ID: 9533260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical advances in AIDS therapy trials.
    Albert JM; Yun H
    Stat Methods Med Res; 2001 Apr; 10(2):85-100. PubMed ID: 11338337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian estimate of the concordance correlation coefficient with skewed data.
    Feng D; Baumgartner R; Svetnik V
    Pharm Stat; 2015; 14(4):350-8. PubMed ID: 26033433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between virologic and immunologic responses in AIDS clinical research using mixed-effects varying-coefficient models with measurement error.
    Liang H; Wu H; Carroll RJ
    Biostatistics; 2003 Apr; 4(2):297-312. PubMed ID: 12925523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jointly Modeling Event Time and Skewed-Longitudinal Data with Missing Response and Mismeasured Covariate for AIDS Studies.
    Huang Y; Yan C; Xing D; Zhang N; Chen H
    J Biopharm Stat; 2015; 25(4):670-94. PubMed ID: 24905593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.